Arcus Biosciences (RCUS) Change in Cash (2017 - 2026)

Arcus Biosciences' Change in Cash history runs 10 years deep, the most recent figure standing at -$21.0 million for Q1 2026.

• On a quarterly basis, Change in Cash fell 150.0% year-over-year to -$21.0 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 28.57% increase from a year earlier, with the FY2025 full-year figure at $72.0 million, up 213.04% from the prior year.
• Change in Cash slipped to -$21.0 million in Q1 2026 per RCUS's latest filing, from -$16.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $401.0 million in Q1 2022 and bottomed at -$276.0 million in Q2 2022.
• The 5-year median for Change in Cash is -$12.0 million (2022), against an average of $3.1 million.
• Across the five-year window, Change in Cash tumbled 375.0% in 2023 and surged 293.1% in 2025, its largest moves.
• Year by year, Change in Cash stood at -$12.0 million in 2022, then tumbled by 375.0% to -$57.0 million in 2023, then climbed by 10.53% to -$51.0 million in 2024, then soared by 68.63% to -$16.0 million in 2025, then tumbled by 31.25% to -$21.0 million in 2026.
• Per Business Quant, the three latest RCUS Change in Cash figures stand at -$21.0 million (Q1 2026), -$16.0 million (Q4 2025), and -$10.0 million (Q3 2025).